Concepedia

Masayuki Ohnaka

MO

7

Publications

261

Citations

7

H-Index

2008

Active since

Affiliations

Kansai Medical University(Current)

Johns Hopkins Medicine

Johns Hopkins University

Kobe University

Gunma University

Masayuki Ohnaka is an author at Kansai Medical University specializing in ophthalmology, medicine, and biomedical engineering.

ORCID

Top concepts

Publications per year

2008–2023

7

Publications

7

Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide

Ron B. Shmueli, Masayuki Ohnaka, Akiko Miki et al. · Biomaterials · 2013 · 57 citations · Full text

, , +7

A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular Neovascularization

Paulina M. Wojnarowicz, Raquel Lima e Silva, Masayuki Ohnaka et al. · Cell Reports · 2019 · 56 citations · Full text

Long‐term expression of glial cell line‐derived neurotrophic factor slows, but does not stop retinal degeneration in a model of retinitis pigmentosa

Masayuki Ohnaka, Katsuaki Miki, Yuanyuan Gong et al. · Journal of Neurochemistry · 2012 · 40 citations · Full text

A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration

Kenji Yamashiro, Keisuke Mori, Shigeru Honda et al. · Scientific Reports · 2017 · 32 citations · Full text

A modified treat-and-extend regimen of aflibercept for treatment-naïve patients with neovascular age-related macular degeneration

Masayuki Ohnaka, Yoshimi Nagai, Kenichiro Sho et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2016 · 31 citations

, , +6

Rows per page

1–5 of 7